OpenURL Connection Search

Select item for more details and to access through your institution.

Infection and replication of human cytomegalovirus in bone marrow stromal cells: effects on the production of IL-6, MIP-1α, and TGF-β1.
Published in:
Bone Marrow Transplantation, 1997, v. 19, n. 5, p. 471, doi. 10.1038/sj.bmt.1700685
By:
- Taichman, R S;
- Nassiri, M R;
- Reilly, M J;
- Ptak, R G;
- Emerson, S G;
- Drach, J C
Publication type:
Article
Fluoreszenz in-situ Hybridisierung: Anforderungen an das Laboratorium und Qualitätskontrolle.
Published in:
Journal of Laboratory Medicine / Laboratoriums Medizin, 1997, v. 21, n. 12, p. 683
By:
- Drach, J.;
- Roka, S.;
- Ackermann, J.;
- Zojer, N.;
- Schuster, R.;
- Fiegl, M.
Publication type:
Article
Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance.
Published in:
2000
By:
- Königsberg, R;
- Ackermann, J;
- Kaufmann, H;
- Zojer, N;
- Urbauer, E;
- Krömer, E;
- Jäger, U;
- Gisslinger, H;
- Schreiber, S;
- Heinz, R;
- Ludwig, H;
- Huber, H;
- Drach, J
Publication type:
journal article
Quantitation of minimal residual disease in acute myelogenous leukemia and myelodysplastic syndromes in complete remission by molecular cytogenetics of progenitor cells.
Published in:
1999
By:
- Engel, H;
- Drach, J;
- Keyhani, A;
- Jiang, S;
- Van, N T;
- Kimmel, M;
- Sanchez-Williams, G;
- Goodacre, A;
- Andreeff, M
Publication type:
journal article
Species Differences in the Metabolism of Diphenhydramine (Benadryl1)2.
Published in:
Proceedings of the Society for Experimental Biology & Medicine, 1970, v. 135, n. 3, p. 849, doi. 10.3181/00379727-135-35157
By:
- Drach, J. C.;
- Howell, J. P.;
- Borondy, P. E.;
- Glazko, A. J.
Publication type:
Article
Efficacy of the combination of bortezomib and dexamethasone in systemic AL amyloidosis.
Published in:
2011
By:
- Lamm, W.;
- Willenbacher, W.;
- Lang, A.;
- Zojer, N.;
- Müldür, E.;
- Ludwig, H.;
- Schauer-Stalzer, B.;
- Zielinski, C.;
- Drach, J.;
- Müldür, E;
- Zielinski, C C
Publication type:
journal article
Somatostatin receptor expression in primary gastric versus nongastric extranodal B-cell lymphoma of mucosa-associated lymphoid tissue type.
Published in:
1999
By:
- Raderer, Markus;
- Valencak, Julia;
- Pfeffel, Franz;
- Drach, Johannes;
- Pangerl, Thomas;
- Kurtaran, Amir;
- Hejna, Michael;
- Vorbeck, Friedrich;
- Chott, Andreas;
- Virgolini, Irene;
- Raderer, M;
- Valencak, J;
- Pfeffel, F;
- Drach, J;
- Pangerl, T;
- Kurtaran, A;
- Hejna, M;
- Vorbeck, F;
- Chott, A;
- Virgolini, I
Publication type:
journal article
Glucocorticoid-mediated immunomodulation: hydrocortisone enhances immunosuppressive endogenous retroviral protein (pl5E) expression in mouse immune cells.
Published in:
Clinical & Experimental Immunology, 1995, v. 101, n. 2, p. 259, doi. 10.1111/j.1365-2249.1995.tb08348.x
By:
- Fiegl, M.;
- Strasser-Wozak, E.;
- Geley, S.;
- Gsur, A.;
- Drach, J.;
- Kofler, R.
Publication type:
Article
Expression of the neural cell adhesion molecule (CD56) by human myeloma cells.
Published in:
Clinical & Experimental Immunology, 1991, v. 83, n. 3, p. 418
By:
- Drach, J.;
- Gattringer, C.;
- Huber, H.
Publication type:
Article
Chromosomal abnormalities of young multiple myeloma patients (<45 yr) are not different from those of other age groups and are independent of stage according to the International Staging System.
Published in:
European Journal of Haematology, 2007, v. 78, n. 3, p. 227, doi. 10.1111/j.1600-0609.2006.00807.x
By:
- Sagaster, V.;
- Kaufmann, H.;
- Odelga, V.;
- Ackermann, J.;
- Gisslinger, H.;
- Rabitsch, W.;
- Zojer, N.;
- Ludwig, H.;
- Nösslinger, T.;
- Zielinski, C.;
- Drach, J.
Publication type:
Article
Chemotherapy for the treatment of patients with primary high grade gastric B-cell lymphoma of modified Ann Arbor Stages IE and IIE.
Published in:
2000
By:
- Raderer, Markus;
- Valencak, Julia;
- Österreicher, Christian;
- Drach, Johannes;
- Hejna, Michael;
- Kornek, Gabriela;
- Scheithauer, Werner;
- Brodowicz, Thomas;
- Chott, Andreas;
- Dragosics, Brigitte;
- Raderer, M;
- Valencak, J;
- Osterreicher, C;
- Drach, J;
- Hejna, M;
- Kornek, G;
- Scheithauer, W;
- Brodowicz, T;
- Chott, A;
- Dragosics, B
Publication type:
journal article
Advances in the biology and therapeutic management of multiple myeloma.
Published in:
2001
By:
- Kaufmann, H.;
- Urbauer, E.;
- Ackermann, J.;
- Huber, H.;
- Drach, J.
Publication type:
journal article
Absence of clonal chromosomal relationship between concomitant B-CLL and multiple myeloma--a report on two cases.
Published in:
2001
By:
- Kaufmann, H.;
- Ackermann, J.;
- Nösslinger, T.;
- Krömer, E.;
- Zojer, N.;
- Schreiber, S.;
- Urbauer, E.;
- Heinz, R.;
- Ludwig, H.;
- Huber, H.;
- Drach, J.;
- Nösslinger, T;
- Krömer, E
Publication type:
journal article
Deletion of chromosome 13q14 detected by fluorescence in situ hybridization has prognostic impact on survival after high-dose therapy in patients with multiple myeloma.
Published in:
2001
By:
- Worel, N.;
- Greinix, H.;
- Ackermann, J.;
- Kaufmann, H.;
- Urbauer, E.;
- Höcker, P.;
- Gisslinger, H.;
- Lechner, K.;
- Kalhs, P.;
- Drach, J.;
- Höcker, P
Publication type:
journal article
Cytogenetic patterns in multiple myeloma after a phase of preceding MGUS.
Published in:
European Journal of Clinical Investigation, 2008, v. 38, n. 1, p. 53, doi. 10.1111/j.1365-2362.2007.01903.x
By:
- Kaufmann, H.;
- Ackermann, J.;
- Odelga, V.;
- Sagaster, V.;
- Nösslinger, T.;
- Pfeilstöcker, M.;
- Keck, A.;
- Ludwig, H.;
- Gisslinger, H.;
- Drach, J.
Publication type:
Article
In vivo effects of imatinib mesylate on human haematopoietic progenitor cells.
Published in:
European Journal of Clinical Investigation, 2006, v. 36, n. 6, p. 402, doi. 10.1111/j.1365-2362.2006.01645.x
By:
- Agis, H.;
- Jaeger, E.;
- Doninger, B.;
- Sillaber, C.;
- Marosi, C.;
- Drach, J.;
- Schwarzinger, I.;
- Valent, P.;
- Oehler, L.
Publication type:
Article
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.
Published in:
2009
By:
- Fonseca, R.;
- Bergsagel, P. L.;
- Drach, J.;
- Shaughnessy, J.;
- Gutierrez, N.;
- Stewart, A. K.;
- Morgan, G.;
- Van Ness, B.;
- Chesi, M.;
- Minvielle, S.;
- Neri, A.;
- Barlogie, B.;
- Kuehl, W. M.;
- Liebisch, P.;
- Davies, F.;
- Chen-Kiang, S.;
- Durie, B. G. M.;
- Carrasco, R.;
- Sezer, Orhan;
- Reiman, Tony
Publication type:
journal article
Expression of MUM1/IRF4 mRNA as a prognostic marker in patients with multiple myeloma.
Published in:
2008
By:
- Heintel, D.;
- Zojer, N.;
- Schreder, M.;
- Strasser-Weippl, K.;
- Kainz, B.;
- Vesely, M.;
- Gisslinger, H.;
- Drach, J.;
- Gaiger, A.;
- Jäger, U.;
- Ludwig, H.
Publication type:
Letter
Bortezomib in relapsed multiple myeloma: response rates and duration of response are independent of a chromosome 13q-deletion.
Published in:
Leukemia (08876924), 2007, v. 21, n. 1, p. 164, doi. 10.1038/sj.leu.2404459
By:
- Sagaster, V.;
- Ludwig, H.;
- Kaufmann, H.;
- Odelga, V.;
- Zojer, N.;
- Ackermann, J.;
- Küenburg, E.;
- Wieser, R.;
- Zielinski, C.;
- Drach, J.
Publication type:
Article
Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma.
Published in:
Leukemia (08876924), 2004, v. 18, n. 11, p. 1879, doi. 10.1038/sj.leu.2403518
By:
- Kaufmann, H;
- Ackermann, J;
- Baldia, C;
- Nösslinger, T;
- Wieser, R;
- Seidl, S;
- Sagaster, V;
- Gisslinger, H;
- Jäger, U;
- Pfeilstöcker, M;
- Zielinski, C;
- Drach, J
Publication type:
Article
Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome.
Published in:
Leukemia (08876924), 2004, v. 18, n. 1, p. 146, doi. 10.1038/sj.leu.2403206
By:
- Simonitsch-Klupp, I.;
- Hauser, I.;
- Ott, G.;
- Drach, J.;
- Ackermann, J.;
- Kaufmann, J.;
- Weltermann, A.;
- Greinix, H.T.;
- Skrabs, C.;
- Dittrich, C.;
- Lutz, D.;
- Pötter, R.;
- Mannhalter, C.;
- Lechner, K.;
- Chott, A.;
- Jaeger, U.
Publication type:
Article
Simultaneous occurrence of chronic myeloid leukemia and multiple myeloma: Evaluation by FISH analysis and in vitro expansion of bone marrow cells.
Published in:
Leukemia (08876924), 2003, v. 17, n. 7, p. 1426, doi. 10.1038/sj.leu.2402971
By:
- Schwarzmeier, J D;
- Shehata, M;
- Ackermann, J;
- Hilgarth, M;
- Kaufmann, H;
- Drach, J
Publication type:
Article
The biological and clinical significance of the KI-67 growth fraction in multiple myeloma.
Published in:
1992
By:
- Drach, Johannes;
- Gattringer, Claus;
- Glassl, Herta;
- Drach, Doris;
- Huber, Heinz;
- Drach, J;
- Gattringer, C;
- Glassl, H;
- Drach, D;
- Huber, H
Publication type:
journal article
Bortezomib Administered Subcutaneously Is Well Tolerated in Bortezomib-Based Combination Regimens Used in Patients with Multiple Myeloma.
Published in:
Oncology, 2013, v. 85, n. 4, p. 223, doi. 10.1159/000355197
By:
- Lamm, W.;
- Drach-Schauer, B.;
- Eder, S.;
- Drach, J.
Publication type:
Article
Academia-pharma intersect: myelomas. Current multiple myeloma treatment strategies with novel agents: a European perspective.
Published in:
2010
By:
- Ludwig H;
- Beksac M;
- Bladé J;
- Boccadoro M;
- Cavenagh J;
- Cavo M;
- Dimopoulos M;
- Drach J;
- Einsele H;
- Facon T;
- Goldschmidt H;
- Harousseau J;
- Hess U;
- Ketterer N;
- Kropff M;
- Mendeleeva L;
- Morgan G;
- Palumbo A;
- Plesner T;
- San Miguel J
Publication type:
Journal Article
Deletions of the region 17p11-13 in advanced melanoma revealed by cytogenetic analysis and fluorescence in situ hybridization.
Published in:
British Journal of Cancer, 1999, v. 79, n. 1, p. 131, doi. 10.1038/sj.bjc.6690022
By:
- Okamoto, I;
- Pirc-Danoewinata, H;
- Ackermann, J;
- Drach, J;
- Wadl, H Schlagbauer;
- Jansen, B;
- Wolff, K;
- Pehamberger, H;
- Marosi, C
Publication type:
Article
Durchflußzytometrischer Nachweis von terminaler Desoxyribonukleotidyl-Transferase (TdT) zur Diagnostik akuter Leukämien.
Published in:
Journal of Laboratory Medicine / Laboratoriums Medizin, 1989, v. 13, n. 1, p. 1
By:
- Drach, J.;
- Gattringer, C.;
- Glassl, H.;
- Huber, H.
Publication type:
Article
Combined flow cytometric assessment of cell surface antigens and nuclear TdT for the detection of minimal residual disease in acute leukaemia.
Published in:
British Journal of Haematology, 1991, v. 77, n. 1, p. 37, doi. 10.1111/j.1365-2141.1991.tb07945.x
By:
- Drach, J.;
- And, C. Gattringer;
- Huber, H.
Publication type:
Article

Found: 28

Infection and replication of human cytomegalovirus in bone marrow stromal cells: effects on the production of IL-6, MIP-1α, and TGF-β<sub>1</sub>.

Fluoreszenz in-situ Hybridisierung: Anforderungen an das Laboratorium und Qualitätskontrolle.

Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance.

Quantitation of minimal residual disease in acute myelogenous leukemia and myelodysplastic syndromes in complete remission by molecular cytogenetics of progenitor cells.

Species Differences in the Metabolism of Diphenhydramine (Benadryl<sup>1</sup>)<sup>2</sup>.

Efficacy of the combination of bortezomib and dexamethasone in systemic AL amyloidosis.

Somatostatin receptor expression in primary gastric versus nongastric extranodal B-cell lymphoma of mucosa-associated lymphoid tissue type.

Glucocorticoid-mediated immunomodulation: hydrocortisone enhances immunosuppressive endogenous retroviral protein (pl5E) expression in mouse immune cells.

Expression of the neural cell adhesion molecule (CD56) by human myeloma cells.

Chromosomal abnormalities of young multiple myeloma patients (<45 yr) are not different from those of other age groups and are independent of stage according to the International Staging System.

Chemotherapy for the treatment of patients with primary high grade gastric B-cell lymphoma of modified Ann Arbor Stages IE and IIE.

Advances in the biology and therapeutic management of multiple myeloma.

Absence of clonal chromosomal relationship between concomitant B-CLL and multiple myeloma--a report on two cases.

Deletion of chromosome 13q14 detected by fluorescence in situ hybridization has prognostic impact on survival after high-dose therapy in patients with multiple myeloma.

Cytogenetic patterns in multiple myeloma after a phase of preceding MGUS.

In vivo effects of imatinib mesylate on human haematopoietic progenitor cells.

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.

Expression of MUM1/IRF4 mRNA as a prognostic marker in patients with multiple myeloma.

Bortezomib in relapsed multiple myeloma: response rates and duration of response are independent of a chromosome 13q-deletion.

Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma.

Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome.

Simultaneous occurrence of chronic myeloid leukemia and multiple myeloma: Evaluation by FISH analysis and in vitro expansion of bone marrow cells.

The biological and clinical significance of the KI-67 growth fraction in multiple myeloma.

Bortezomib Administered Subcutaneously Is Well Tolerated in Bortezomib-Based Combination Regimens Used in Patients with Multiple Myeloma.

Academia-pharma intersect: myelomas. Current multiple myeloma treatment strategies with novel agents: a European perspective.

Deletions of the region 17p11-13 in advanced melanoma revealed by cytogenetic analysis and fluorescence in situ hybridization.

Durchflußzytometrischer Nachweis von terminaler Desoxyribonukleotidyl-Transferase (TdT) zur Diagnostik akuter Leukämien.

Combined flow cytometric assessment of cell surface antigens and nuclear TdT for the detection of minimal residual disease in acute leukaemia.